Products with Antifungal bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN3857 | (-)-beta-Pinene |
| Important intermed. in manuf. of synthetic aroma compds. Flavouring ingredient. | |
| BCN3893 | Medicagenic acid |
| 1. Medicagenic acid derivatives exhibit potent fungistatic effects against several plant pathogens and human dermatophytes. 2. Medicagenic acid, the factor responsible for hemolytic activity of lucerne saponins. | |
| BCN3895 | beta-Thujaplicin |
| 1. Hinokitiol can inhibit ultraviolet B-induced apoptosis in keratinocytes and strongly suggest that the inhibitory mechanism is due to the antioxidant activity of metallothionein induced by the agent. 2. Hinokitiol has antibacterial effect , it can inhibit all Staphylococcus aureus isolates with MICs of 1.56-3.13 mg/L. 3. Hinokitiol has antifungal activity against 51 Malassezia pachydermatis strains, it is an inexpensive and safe treatment with anti-inflammatory and deodorant effects that can be recommended as an effective remedy for canine otitis externa. 4. beta-thujaplicin (Hinokitiol) has ability to extract mitochondrial Mg++ and the prevention of the effects of beta-thujaplicin by an excess of Mg++ in the medium, suggests a common mode of action of beta-thujaplicin as a lipophilic chelator of Mg++ and other divalent cations. | |
| BCN3962 | Phaseollidin hydrate |
| 1. Phaseollidin hydrate shows less antifungal activity than the original phytoalexin phaseollidin. | |
| BCN4029 | Cyclo(L-Phe-L-Pro) |
| 1. Cyclo(L-Phe-L-Pro) shows antifungal and broad spectrum antibacterial activities. 2. Cyclo-(L-Phe-L-Pro) exhibits activity against methicillin-resistant S. aureus ATCC 43300 and Enterococcus raffinosus, with low toxicity against human hepatoma HepaRG cells. | |
